Patent · US Active

Angiopoietin derived peptides

US9255132B2 · kind B2 · utility

0Cited by
4References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 18, 2013
Grant dateFeb 9, 2016
Priority date
Expiry dateJun 18, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K9/001
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are angiopoietin-derived peptides or homologs or derivatives thereof, pharmaceutical composition including them, a use thereof for therapy and for the manufacture of a medicament, a method of treating a wide range of conditions, disorders and diseases therewith, nucleotide sequences encoding them, antibodies directed to epitopes thereof and fusion proteins including them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.